HCL Technologies Q4 Review - Healthy Deal Wins, Guidance Key Positives: ICICI Direct
The HCL Technologies LTD. Jigani campus stands deserted in Bengaluru, India (Photographer Samyukta Lakshmi/Bloomberg)

HCL Technologies Q4 Review - Healthy Deal Wins, Guidance Key Positives: ICICI Direct


BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

ICICI Direct Report

HCL Technologies Ltd.’s results were below our expectations. However, the company won 19 transformational deals across industry verticals.

New deal total contract value in this quarter increased 49% YoY at $3.1 billion and 18% YoY to $7.3 billion in FY21.

Further, in terms of guidance, the company expects to grow in double digits in constant currency for FY22E and expects Ebit margin to be between 19.0% and 21.0% for FY22E.

The company has declared a dividend of Rs 6/share.

Also, the board has declared a special dividend of Rs 10/share.

Click on the attachment to read the full report:

ICICI Direct HCL Technologies Q4FY21 Result Review.pdf


This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.